14 results
DEF 14A
TEVA
Teva- Pharmaceutical Industries Ltd.
25 Apr 18
Definitive proxy
12:00am
for any corporate purpose, and the Designated Employer shall not be obligated to segregate such payroll deductions.
16. Reports. Individual accounts
6-K
EX-1.2
TEVA
Teva- Pharmaceutical Industries Ltd.
18 Jun 10
Current report (foreign)
12:00am
or regulated, whose corporate purpose is solely to invest in securities; (ii) to any legal entity that has two or more of (1) an average of at least 250
6-K
EX-1.1
TEVA
Teva- Pharmaceutical Industries Ltd.
18 Jun 10
Current report (foreign)
12:00am
or, if not so authorized or regulated, whose corporate purpose is solely to invest in securities; (ii) to any legal entity that has two or more of (1
424B5
Teva Pharmaceutical Finance Iii LLC
16 Jun 10
Prospectus supplement for primary offering
12:00am
corporate purpose is solely to invest in securities;
(b) to any legal entity which has two or more of (1) an average of at least 250 employees during
6-K
TEVA
Teva- Pharmaceutical Industries Ltd.
23 May 08
Current report (foreign)
12:00am
Designated Employer under the Plan may be used by such Designated Employer for any corporate purpose, and the Designated Employer shall not be obligated
6-K
EX-1.2
looev4b0t8qf
31 Jan 06
Current report (foreign)
12:00am
6-K
EX-1.1
xz42c00puui4i4gd
31 Jan 06
Current report (foreign)
12:00am
6-K
EX-1.3
k7ckokzmg0zhchqjxje
31 Jan 06
Current report (foreign)
12:00am
424B5
cc6dnhd8pdh
30 Jan 06
Prospectus supplement for primary offering
12:00am
424B5
ifw05
30 Jan 06
Prospectus supplement for primary offering
12:00am
424B5
71lcws3xh aamo4fy6p5
30 Jan 06
Prospectus supplement for primary offering
12:00am
424B5
oh9zw
26 Jan 06
Prospectus supplement for primary offering
12:00am
424B5
bxrwhw57
26 Jan 06
Prospectus supplement for primary offering
12:00am
424B5
l0a12r6os879dh9bf84a
26 Jan 06
Prospectus supplement for primary offering
12:00am
- Prev
- 1
- Next